TuHURA Biosciences, Inc.  ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that an abstract highlighting ...

Abstract: Graph-to-text generation for specialized tasks, such as scientific abstract generation, is challenging due to the limited availability of structured knowledge graphs and the need to balance ...